Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
Status:
Terminated
Trial end date:
2018-10-07
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if lenalidomide, when given with a stem
cell transplant and chemotherapy (bendamustine, fludarabine, and rituximab), can help to
control CLL. The safety of this treatment combination will also be studied.